Duality Advisers, LP Myriad Genetics Inc Transaction History

Duality Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 27, 2023	SELL	$15.26 - $23.75 $508,386 - $791,231	-33,315 Reduced 63.05%	19,528 $453,000
Q4 2022 Feb 07, 2023	BUY	$14.51 - $20.99 $766,751 - $1.11 Million	52,843 New	52,843 $766,000
Q2 2022 Aug 08, 2022	BUY	$16.45 - $25.88 $348,542 - $548,345	21,188 New	21,188 $385,000
Q1 2022 May 09, 2022	SELL	$22.67 - $28.01 $968,915 - $1.2 Million	-42,740 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$24.13 - $32.63 $1.03 Million - $1.39 Million	42,740 New	42,740 $1.18 Million
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $1.19 Million - $1.93 Million	-97,680 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$11.25 - $14.75 $742,916 - $974,045	-66,037 Reduced 40.34%	97,680 $1.27 Million
Q2 2020 Jul 29, 2020	BUY	$10.69 - $16.49 $1.75 Million - $2.7 Million	163,717 New	163,717 $1.86 Million

237

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.